Research Article
Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin’s Lymphoma and Role of β2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China
Figure 4
Subgroup survival curves of patients before treatment: (a) PFS of the mg/L group (blue) and the mg/L group (red); (b) OS of the mg/L group and the mg/L group.
(a) |
(b) |